www.fdanews.com/articles/123603-pharmavigilant-inks-contract-with-synergy-pharmaceuticals
PharmaVigilant Inks Contract With Synergy Pharmaceuticals
January 12, 2010
PharmaVigilant, a clinical trial technology provider, has been selected by
Synergy Pharmaceuticals Inc. to support its one-year, multi-center Phase II study focused on the development of a new drug to treat gastrointestinal disorders
and diseases.
GEN
GEN